meperidine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alkadhi, KA; Hogan, YH | 1 |
Chesher, G | 1 |
Baldessarini, RJ; Neumeyer, JL | 1 |
Johannessen, JN; Markey, SP | 1 |
Bédard, PJ; Gomez-Mancilla, B | 1 |
Bossù, E; Cotechini, V; Donati, E; Farina, A; Quaglia, MG | 1 |
Bossù, E; Farina, A; Gostoli, G; Lecce, R; Lestingi, C; Montinaro, A | 1 |
9 other study(ies) available for meperidine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on ganglionic transmission.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Electric Stimulation; Ganglia, Sympathetic; In Vitro Techniques; Male; Meperidine; Methadone; Morphine; Naloxone; Rats; Rats, Inbred Strains; Synaptic Transmission | 1992 |
Designer drugs--the "whats" and the "whys".
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Designer Drugs; Doping in Sports; Drug Design; Fentanyl; Humans; Illicit Drugs; Legislation, Drug; Meperidine; Phenethylamines; Structure-Activity Relationship | 1990 |
Lack of depletion of striatal dopamine by phenylpiperidine analgesics.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alphaprodine; Analgesics; Animals; Corpus Striatum; Dopamine; Meperidine; Mice; Pyridines | 1986 |
Assessment of the opiate properties of two constituents of a toxic illicit drug mixture.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analgesics, Opioid; Animals; Drug Combinations; Exploratory Behavior; Illicit Drugs; In Vitro Techniques; Male; Meperidine; Naloxone; Narcotics; Pharmacology; Pyridines; Rats; Receptors, Opioid; Reflex; Respiration | 1984 |
Street-drug contaminant causing parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Drug Contamination; Humans; Illicit Drugs; Meperidine; Parkinson Disease, Secondary; Pharmaceutical Preparations; Pyridines; Substance-Related Disorders | 1984 |
Leads from the MMWR. Street-drug contaminant causing parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Drug Contamination; Humans; Illicit Drugs; Meperidine; Parkinson Disease, Secondary; Pharmaceutical Preparations; Pyridines; Substance-Related Disorders | 1984 |
Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Atropine; Baclofen; Clonidine; Dopamine Agents; Drug Interactions; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Meperidine; Methoxydimethyltryptamines; Neurotransmitter Agents; Yohimbine | 1993 |
Determination of MPTP, a toxic impurity of pethidine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analgesics, Opioid; Chromatography, High Pressure Liquid; Chromatography, Micellar Electrokinetic Capillary; Drug Contamination; Electrophoresis, Capillary; Indicators and Reagents; Meperidine; Reference Standards | 2003 |
LC-MS determination of MPTP at sub-ppm level in pethidine hydrochloride.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Chromatography, Liquid; Mass Spectrometry; Meperidine; Spectrometry, Mass, Electrospray Ionization | 2005 |